Porphyromonas gingivalis, a keystone pathogen in chronic periodontitis secretes a large variety of virulence factors, including an enzyme, peptidylarginine deiminase (PAD), unique for pathogenic species of the Porphyromonas genus. Alike human endogenous PADs, the bacterial enzyme converts arginine residues in proteins to citrulline but it has a strong preference for C-terminal Arg. We postulated that P. gingivalis PAD (PPAD) activity not only contributes to pathogenesis of periodontitis but also it may be involved in the breakdown of immunotolerance and the development of rheumatoid arthritis (RA), a diseases driven by autoantibodies targeting citrullinated epitopes. This contention is supported by findings that PPAD, in conjunction with Arg-specific gingipain proteases (Rgps), can generate a large spectrum of citrullinated peptides derived from bacterial and host proteins, including fibrinogen and enolase ? both accepted autoantigens in RA. Also, citrullinated proteins of P. gingivalis stimulate human gingival fibroblasts (HGF) to produce prostaglandin E2 (PGE2), one of the most potent mediators of bone resorption implicated in the pathogenesis of PD and RA. Moreover, our unpublished data show that both resting and P. gingivalis citrullinome-stimulated HGFs, derived from periodontitis patients, produce significantly more PGE2 than cells from healthy donors. Finally, we discovered two allelic forms of the ppad gene among P. gingivalis clinical isolates, one encoding a superactive isoform of the enzyme, which crystal structure suggests that it binds substrates with higher affinity than the other form of PPAD. The tighter substrate binding may contribute to proposed second important function of PPAD as the carrier protein of haptens (bacteria and/or host protein- derived citrullinated peptides) presented to B cell, followed by T cell activation and the breakdown of immunotolerance in a hapten/carrier mechanism. Based on these findings we postulate that PPAD is directly responsible for the breakdown of immunotolerance and subsequent anti-citrullinated protein antibody (ACPA) production - key pathological events preceding clinical onset of RA; and the severity of PD and its link to RA is associated with the occurrence of a superactive variant of PPAD expressed by subset of P. gingivalis strains. To experimentally verify these hypotheses, we propose the following specific aims: (i) investigate the functional relevance of citrullinated bacterial proteins in pathological interactions between P. gingivalis and fibroblasts; (ii) determine if PPAD targeting by T cells provides help for the production of ACPA through a hapten/carrier mechanism; and (iii) analyse the prevalence of P. gingivalis strains carrying the superactive PPAD gene in the context of the severity of PD and relation to associated RA. Successful completion of this project will drive the field forward by providing a novel perspective to the understanding the pathogenesis of PD-RA associations, thus offering venues to develop novel strategies to treat these debilitating diseases.

Public Health Relevance

Porphyromonas gingivalis, an established periodontal pathogen, is able to produce citrullinated proteins through the action of an enzyme (PPAD) unique to this bacterium. Citrullinated bacterial proteins are able to induce human fibroblasts to produce prostaglandin E2 (PGE2) which can stimulate the bone resorption process implicated in the pathogenesis in periodontitis and rheumatoid arthritis (RA). PPAD may also directly promote breakdown of self-tolerance in susceptible individuals to generate autoantibodies against citrullinated self- proteins in the development of RA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE022597-07
Application #
9886230
Study Section
Oral, Dental and Craniofacial Sciences Study Section (ODCS)
Program Officer
Chander, Preethi
Project Start
2013-02-01
Project End
2024-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Louisville
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Kriebel, Katja; Hieke, Cathleen; Engelmann, Robby et al. (2018) Porphyromonas gingivalis Peptidyl Arginine Deiminase Can Modulate Neutrophil Activity via Infection of Human Dental Stem Cells. J Innate Immun 10:264-278
Eckert, M; Mizgalska, D; Sculean, A et al. (2018) In vivo expression of proteases and protease inhibitor, a serpin, by periodontal pathogens at teeth and implants. Mol Oral Microbiol 33:240-248
Grabiec, Aleksander M; Potempa, Jan (2018) Epigenetic regulation in bacterial infections: targeting histone deacetylases. Crit Rev Microbiol 44:336-350
Wong, Alicia; Bryzek, Danuta; Dobosz, Ewelina et al. (2018) A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential of Cell-Free DNA. J Immunol 200:2327-2340
Schwenzer, Anja; Quirke, Anne-Marie; Marzeda, Anna M et al. (2017) Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis. Arthritis Rheumatol 69:2303-2313
Gawron, K; Bereta, G; Nowakowska, Z et al. (2017) Analysis of mutations in the SOS-1 gene in two Polish families with hereditary gingival fibromatosis. Oral Dis 23:983-989
Kariu, T; Nakao, R; Ikeda, T et al. (2017) Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids. J Periodontal Res 52:89-96
Wilensky, A; Potempa, J; Houri-Haddad, Y et al. (2017) Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss. J Periodontal Res 52:285-291
Kharlamova, Nastya; Jiang, Xia; Sherina, Natalia et al. (2016) Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology. Arthritis Rheumatol 68:604-13
Koneru, Lahari; Ksiazek, Miroslaw; Waligorska, Irena et al. (2016) Mirolysin, a LysargiNase from Tannerella forsythia, proteolytically inactivates the human cathelicidin, LL-37. Biol Chem :

Showing the most recent 10 out of 50 publications